Experts seek painkiller ban

Last updated 05:00 14/02/2013

Relevant offers

Health

Manawatu people donne red and walk for Cure Kids Mother struggles to get her daughter treatment Snowboarder lucky to be alive after falling 20m down a cliff Victory in Keytruda campaign comes too late for Jeff Paterson who passes away after cancer battle Outgoing Police Association boss explores the effects of cannabis decriminalisation Texting your way to a fitter, healthier life The obese 'are not lazy, lacking in motivation or stupid', says obesity expert New Zealand has world's second highest rate of workplace bullying Poisoning the wells: a history of infected drinking water in Canterbury Kidney transplant from sister helps athlete compete

A popular painkiller should be banned worldwide because it raises the risk of heart attack and stroke by almost half, British academics say.

Risks from diclofenac, widely sold as Voltaren, were highest in those who used it regularly, and safer options were available, they said.

Medsafe in New Zealand said it would consider the research, but noted previous reviews had shown its benefits outweighed potential risks.

Diclofenac is a non-steroidal anti-inflammatory drug often prescribed after surgery or to combat arthritic pain when other painkillers are not strong enough.

It has been available in New Zealand for more than 20 years. I

t is subsidised by state drug-buying agency Pharmac, with 375,000 people being prescribed it in the year ending November 2012. That figure does not include those who buy it over the counter.

Ad Feedback

- The Dominion Post

Special offers
Opinion poll

Should fluoride in water be the responsibility of central government?

Yes

No

Vote Result

Featured Promotions

Sponsored Content